In this Journal of Opioid Management op-ed, Center for U.S. Policy Senior Fellow Lynn Webster, M.D., and co-authors explain that state licensing boards and civil lawsuits, along with the federal government’s administrative framework, are more appropriate forums than federal criminal courts when dealing with questions surrounding medical care
Thirty-three not-for-profit organizations sent a letter to commend Members of Congress for introducing a bill to provide Medicare coverage and create a new Medicaid payment category for prescription digital therapies. The “Access to Prescription Digital Therapeutics Act of 2022” is sponsored by Sens. Jeanne Shaheen (NH) and Shelley Moore Capito (WV), and Reps. Mike Thompson (CA-5) and David McKinley (WV-01).
The Center for U.S. Policy, Aimed Alliance, and the International Health Facility Diversion Association commended the federal government for facilitating patient access to prescription digital behavioral therapies. “We thank CMS for acting with speed to expand access to evidence-based digital therapies for behavioral health.”
We are pleased to announce that our Chairman @MCBtweets will be special editor of the legal-legislative-regulatory issue of the Journal of Opioid Management.
Learn more here: https://www.wmpllc.org/ojs/index.php/jom/pages/view/Legal
Please join us!
Honored to have been part of the @theNASEM Workshop on Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change,” The workshop’s report is out today with a masterful recitation of participants’ recommendations.
https://nap.nationalacademies.org/catalog/26635/methadone-treatment-for-opioid-use-disorder-improving-access-through-regulatory
